Serial Number | 97227033 |
Word Mark | PHARMACEUTICALLY ELEGANT |
Filing Date | Wednesday, January 19, 2022 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Tuesday, May 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 10, 2022 |
Goods and Services | Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches |
NOT AVAILABLE | "PHARMACEUTICALLY" |
Goods and Services | Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, January 25, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, January 25, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Aquestive Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Warren, NJ 07059 |
Party Name | Aquestive Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Warren, NJ 07059 |
Event Date | Event Description |
Monday, March 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Saturday, January 22, 2022 | NEW APPLICATION ENTERED |
Tuesday, January 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, March 16, 2022 | ASSIGNED TO EXAMINER |
Monday, March 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
Monday, March 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, March 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
Friday, April 1, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 20, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 10, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, May 10, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 5, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Thursday, August 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, August 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, August 25, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, August 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 14, 2022 | SOU TEAS EXTENSION RECEIVED |
Wednesday, December 14, 2022 | SOU EXTENSION 1 FILED |
Wednesday, December 14, 2022 | SOU EXTENSION 1 GRANTED |
Friday, December 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, February 13, 2023 | ASSIGNED TO EXAMINER |
Tuesday, May 30, 2023 | SOU TEAS EXTENSION RECEIVED |
Tuesday, May 30, 2023 | SOU EXTENSION 2 FILED |
Tuesday, May 30, 2023 | SOU EXTENSION 2 GRANTED |
Thursday, June 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, November 13, 2023 | SOU EXTENSION 3 GRANTED |
Monday, November 13, 2023 | SOU TEAS EXTENSION RECEIVED |
Monday, November 13, 2023 | SOU EXTENSION 3 FILED |
Tuesday, May 14, 2024 | SOU EXTENSION 4 GRANTED |
Tuesday, May 14, 2024 | SOU EXTENSION 4 FILED |
Tuesday, May 14, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, July 26, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, July 26, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Friday, July 26, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, July 26, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, November 15, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |